Anzeige
Mehr »
Sonntag, 26.10.2025 - Börsentäglich über 12.000 News
Das nächste Lila Sciences? Telescope Innovations ist das 30-Millionen-Dollar-Tor zu KI-gesteuerter Chemie
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von FiercePharma

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
15.09.From the press box: Messages of resilience, authenticity resonated at Fierce Pharma Week 2025
15.09.FDA's Marty Makary deems DTC drug advertising 'a public health crisis' in JAMA editorial
15.09.BMS sells controlling stake in historic US-China pharmaceutical joint venture
15.09.Fiercest Women in Life Sciences 2025: Nominations open now-TWO WEEKS LEFT
12.09.'Keep doing what you're doing': Marketing policy experts unfazed by threats to DTC drug advertising
12.09.Trump officials eye connection between COVID shots, child deaths ahead of ACIP meeting: WaPo
12.09.Chronic disease treatment ads have sparked action in two-thirds of patients: survey
12.09.Gilead prevails in whistleblower lawsuit over alleged hepatitis C prescription kickbacks
12.09.Appeals court knocks back Novartis' IRA challenge one week after rejecting bid by BMS, J&J
11.09.Amid restructuring, Novo Nordisk directs employees to return to office
11.09.AbbVie settles with generic Rinvoq hopefuls, shielding the immunology med's US stronghold until 2037
11.09.Intercept, after many setbacks, pulls liver disease drug Ocaliva in US
11.09.Despite being designed for seniors, Merck's pneumococcal shot shows potential in children
11.09.FibroGen pays SEC $1.2M over allegations former exec 'reverse engineered' roxadustat data
11.09.Chicago private equity firm inks €4.1B purchase of former Sanofi generics unit Zentiva: FT
11.09.Sun's Gujarat facility put on FDA import alert for persistent production shortfalls
11.09.Sanofi, Gilead, Acadia win big at the 2025 Fierce Pharma Marketing Awards
11.09.API maker Hikal hit with FDA warning letter after repeat contamination complaints
10.09.Editor's Corner-For the first PD-1xVEGF's sake, Summit must submit to Big Pharma, stat
10.09.For pharmas looking to 'break through the clutter' and reach patients, relatability is the key
10.09.'Land mines everywhere': How pharma communications keep up under a political spotlight
10.09.Sanofi rounds up 'celebrity mom squad' for Beyfortus RSV campaign
10.09.Trump directs FDA to limit DTC drug advertising, with legal challenges sure to follow
10.09.J&J's 'practice-changing' bladder cancer drug-device combo Inlexzo lands FDA nod
10.09.Trump admin mulls 'severe restrictions' on US pharmas licensing Chinese meds: NYT